SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
批准号:
10721125
负责人:
PAUL PEARSON
金额:
$1.32万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-01 至 2023-06-30
关键词:
AddressChemistryClinical ResearchConsultContractorDataDevelopmentDrug KineticsElectronic MailExperimental DesignsFormulationInvestigational DrugsLeadProtocols documentationReportingServicesTelephoneUnited States National Institutes of Healthassay developmentdesigndrug developmentdrug discoverydrug metabolismlead optimizationprograms
中文摘要
承包商应向NIH蓝图神经治疗网络提供咨询支持服务,
如下所示:
·评估药代动力学研究方案和数据,以确定潜在的药物发现和开发
挑战提出应对这些挑战的战略建议。
·制定计划,协助NIH BPN工作人员战略性地管理药代动力学项目,以促进分析
开发、探索性化学、电极导线优化、制剂活动、研究性新药(IND)
和临床研究。
·协助NIH BPN工作人员设计调查性药代动力学研究,包括研究策略和实验
设计提供关于建议的研究里程碑的建议,并准备里程碑报告。
·通过电话和电子邮件促进领导开发团队关于指定药物代谢的讨论
和药代动力学的努力。
·分析和解释药代动力学药物发现,开发和转化项目的数据。
英文摘要
The Contractor shall provide consulting support services to the NIH Blueprint Neurotherapeutics Network as
follows:
• Evaluate pharmacokinetics study protocols and data to identify potential drug discovery and development
challenges. Recommend strategies to address these challenges.
• Develop plans to assist NIH BPN staff in strategically managing pharmacokinetic programs which facilitate assay
development, exploratory chemistry, lead optimization, formulation activities, investigational new drug (IND)
enabling, and clinical studies.
• Assist NIH BPN staff to design investigative pharmacokinetics studies, including study strategy and experimental
design. Provide advice regarding recommended study milestones and prepare milestone reports are needed.
• Facilitate Lead Development Team discussions via telephone and email regarding assigned drug metabolism
and pharmacokinetics efforts.
• Analyze and interpret data for pharmacokinetics drug discovery, development, and translational projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
-
批准号:10721124
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2022
-
负责人:PAUL PEARSON
-
依托单位:--
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
-
批准号:10788018
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2022
-
负责人:PAUL PEARSON
-
依托单位:--
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
-
批准号:10788017
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2022
-
负责人:PAUL PEARSON
-
依托单位:--
DMPK CONSULTING SUPPORT SERVICES
-
批准号:10495521
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2021
-
负责人:PAUL PEARSON
-
依托单位:--
DMPK CONSULTING SUPPORT SERVICES
-
批准号:10619428
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2021
-
负责人:PAUL PEARSON
-
依托单位:--
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:8356074
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:8429009
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:
TAS::75 0849::TAS TOPIC 255 SELECTIVE AND POTENT INHIBITORS OF TUMOR SPECIFIC GL
-
批准号:8351294
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:9035331
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:--
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:8844712
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:--
NIH DRUG DEVELOPMENT CONSULTING SERVICES
-
批准号:8602417
-
项目类别:
-
资助金额:$11.2万
-
财政年份:2011
-
负责人:PAUL PEARSON
-
依托单位:
国内基金
海外基金
SCIENCE CHINA Chemistry
-
批准号:21224001
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:朱晓文
-
依托单位:
Science China Chemistry
-
批准号:21024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:朱晓文
-
依托单位:
运用Linkage Chemistry合成新型聚合物缀合物和刷形共聚物
-
批准号:20974058
-
项目类别:面上项目
-
资助金额:12.0万元
-
批准年份:2009
-
负责人:袁金颖
-
依托单位: